{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:26Z","timestamp":1787010146215,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82172336"],"award-info":[{"award-number":["No. 82172336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the \u00e2\u20ac\u0153Pioneer\u00e2\u20ac\u009d and \u00e2\u20ac\u0153Leading Goose\u00e2\u20ac\u009d R&D Program of Zhejiang","award":["No. 2022C03118, 2023C03075"],"award-info":[{"award-number":["No. 2022C03118, 2023C03075"]}]},{"name":"the precision medicine key project of Wuxi health commission","award":["J202001"],"award-info":[{"award-number":["J202001"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,20]]},"abstract":"<jats:p>\n                    Lupus nephritis (LN) constitutes a substantial contributor to morbidity and mortality in systemic lupus erythematosus (SLE). The monitoring of renal function in patients with LN is associated with improved prognostication. The objective of this study was to evaluate the clinical utility of serum galectin-3 (Gal-3) levels in differentiating LN from SLE. Moreover, we sought to ascertain whether serum galectin-3 levels can serve as a marker for the degree of renal impairment in patients with LN. In this cross-sectional study, 42 patients with LN and 12 patients with SLE without nephritis were enrolled. Furthermore, 110 healthy subjects were recruited as controls. Serum Gal-3 levels were quantified using a time-resolved fluoroimmunoassay. Furthermore, Gal-3 levels were analyzed in conjunction with other clinical variables. The results demonstrated that patients with LN exhibited a significantly elevated serum Gal-3 concentration (35.98\u2005\u00b1\u200520.68\u2009ng\/mL) in comparison to healthy controls (10.11\u2005\u00b1\u20052.75\u2009ng\/mL,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) and patients with SLE (14.38\u2005\u00b1\u20052.26,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). The area under the curve of Gal-3 in distinguishing patients with SLE from patients with LN was 0.9157. When the cutoff value was set to 18.91\u2009ng\/mL, the sensitivity was 83.33%, and the specificity was 100%. There was a tendency for serum Gal-3 levels to increase with worsening renal impairment in patients with LN. In conclusion, Gal-3 could be a valuable biomarker for distinguishing LN from SLE, providing a useful clinical reference. Elevated serum Gal-3 levels may be associated with the severity of renal impairment in patients with LN.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000040987","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T15:01:48Z","timestamp":1734706908000},"page":"e40987","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Serum galectin-3 can help distinguish lupus nephritis from systemic lupus erythematosus and is also correlated with the degree of renal damage in lupus nephritis"],"prefix":"10.1097","volume":"103","author":[{"given":"Jialong","family":"Wu","sequence":"first","affiliation":[{"name":"College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Yu","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Wuxi People\u2019s Hospital affiliated to Nanjing Medical University, Wuxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qin","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1883-0670","authenticated-orcid":false,"given":"Biao","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Geriatric Hospital of Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","article-title":"What is damaging the kidney in lupus nephritis?","volume":"12","author":"Davidson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis.","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.03280807","article-title":"Value of a complete or partial remission in severe lupus nephritis.","volume":"3","author":"Chen","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited.","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaut.2016.06.006","article-title":"Lupus nephritis: when and how often to biopsy and what does it mean?","volume":"74","author":"Moroni","year":"2016","journal-title":"J Autoimmun"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000511268","article-title":"Update on lupus nephritis: looking for a new vision.","volume":"145","author":"Morales","year":"2021","journal-title":"Nephron"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7150\/thno.22196","article-title":"Galectin-3 activation and inhibition in heart failure and cardiovascular disease: an update.","volume":"8","author":"Suthahar","year":"2018","journal-title":"Theranostics"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1515\/cclm-2014-0187","article-title":"Galectin-3 in diabetic patients.","volume":"52","author":"Pugliese","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.autrev.2016.09.023","article-title":"Role of galectin-3 in autoimmune and non-autoimmune nephropathies.","volume":"16","author":"Saccon","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1373\/clinchem.2015.246553","article-title":"Short- and long-term biologic variability of galectin-3 and other cardiac biomarkers in patients with stable heart failure and healthy adults.","volume":"62","author":"Schindler","year":"2016","journal-title":"Clin Chem"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13054-021-03538-0","article-title":"Galectin-3 in septic acute kidney injury: a translational study.","volume":"25","author":"Sun","year":"2021","journal-title":"Crit Care"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1007\/s00125-018-4552-z","article-title":"Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus.","volume":"61","author":"Tan","year":"2018","journal-title":"Diabetologia"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0961203308094361","article-title":"Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis.","volume":"18","author":"Kang","year":"2009","journal-title":"Lupus"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0006-291X(02)00637-X","article-title":"Identification of autoantibodies associated with systemic lupus erythematosus.","volume":"295","author":"Lim","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices.","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1681\/ASN.2015060612","article-title":"Mayo clinic\/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN.","volume":"27","author":"Sethi","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10895-022-02888-4","article-title":"Establishment of galectin-3 time-resolved fluoroimmunoassay and its application in idiopathic membranous nephropathy.","volume":"32","author":"Yu","year":"2022","journal-title":"J Fluoresc"},{"issue":"Suppl5","key":"R19-20250503","doi-asserted-by":"crossref","first-page":"v39","DOI":"10.1093\/rheumatology\/keaa381","article-title":"Lupus nephritis: clinical presentations and outcomes in the 21st century.","volume":"59","author":"Gasparotto","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 update of the joint European league against rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis.","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.gpb.2013.05.003","article-title":"Biomarker profiling for lupus nephritis.","volume":"11","author":"Li","year":"2013","journal-title":"Genomics Proteomics Bioinform"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000446376","article-title":"Galectin-3 in renal pathology: more than just an innocent bystander.","volume":"43","author":"Desmedt","year":"2016","journal-title":"Am J Nephrol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.kint.2017.06.028","article-title":"Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.","volume":"93","author":"Rebholz","year":"2018","journal-title":"Kidney Int"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/ijms17040565","article-title":"The role of galectin-3 in the kidneys.","volume":"17","author":"Chen","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.","volume":"13","author":"Yu","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/09612033221145534","article-title":"Urine galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.","volume":"32","author":"Faustini","year":"2023","journal-title":"Lupus"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5114\/ada.2020.92320","article-title":"Serum galectin-3 and galectin-3 binding protein levels in systemic lupus erythematosus and cutaneous lupus erythematosus.","volume":"38","author":"Kalinska-Bienias","year":"2021","journal-title":"Postepy Dermatol Alergol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2019.03.004","article-title":"Refractory lupus nephritis: when, why and how to treat.","volume":"18","author":"Kronbichler","year":"2019","journal-title":"Autoimmun Rev"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0961203310371154","article-title":"The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.","volume":"19","author":"Birmingham","year":"2010","journal-title":"Lupus"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3899\/jrheum.100007","article-title":"Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome.","volume":"37","author":"Steiman","year":"2010","journal-title":"J Rheumatol"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"25343","DOI":"10.1074\/jbc.M115.647008","article-title":"Functional characterization of autoantibodies against complement component C3 in patients with lupus nephritis.","volume":"290","author":"Vasilev","year":"2015","journal-title":"J Biol Chem"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases.","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"14317","DOI":"10.3390\/ijms232214317","article-title":"Renal fibrosis in lupus nephritis.","volume":"23","author":"Sciascia","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","article-title":"Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis.","volume":"172","author":"Henderson","year":"2008","journal-title":"Am J Pathol"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"44684","DOI":"10.1074\/jbc.M112.426445","article-title":"Epigenetic regulation of galectin-3 expression by \u03b21 integrins promotes cell adhesion and migration.","volume":"287","author":"Margadant","year":"2012","journal-title":"J Biol Chem"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.3390\/ijms22105144","article-title":"Interaction between galectin-3 and integrins mediates cell-matrix adhesion in endothelial cells and mesenchymal stem cells.","volume":"22","author":"Sedl\u00e1\u0159","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:29:19Z","timestamp":1746304159000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":36,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040987","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}